Prelude Capital Management, LLC Talis Biomedical Corp Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.81 - $1.44 $26,293 - $46,743
-32,461 Reduced 12.66%
223,934 $182,000
Q1 2022

May 16, 2022
BUY
$1.3 - $4.19 $88,563 - $285,447
68,126 Added 36.19%
256,395 $362,000
Q4 2021

Feb 14, 2022
BUY
$3.81 - $6.17 $670,300 - $1.09 Million
175,932 Added 1426.05%
188,269 $755,000
Q3 2021

Nov 15, 2021
BUY
$6.02 - $12.46 $74,268 - $153,719
12,337 New
12,337 $77,000

About Talis Biomedical Corp

TLIS Quotes by TradingView
  • Ticker TLIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,619,200
  • Market Cap $47.9M
  • Description
  • Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...
More about TLIS
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email